News

Innovations in Sequencing from New England Biolabs at AGBT 2025

Innovations in Sequencing from New England Biolabs at AGBT 2025

New Innovations by New England Biolabs in Sequencing Technology

New England Biolabs (NEB) is stepping into the spotlight by showcasing groundbreaking technologies aimed at streamlining sample preparation for next-generation sequencing. With a commitment to advancing molecular biology research, NEB is presenting a range of innovative solutions that promise to enhance the quality and efficiency of sequencing data production.

Overview of Presentations at AGBT 2025

This year's Advances in Genome Biology and Technology (AGBT) General Meeting serves as an ideal platform for NEB to reveal its latest advancements. Presentations will cover a wide array of technologies, including the highly anticipated NEBNext Enzymatic Methyl-seq v2 kit, which significantly broadens the technology’s input range, making it suitable for a diverse spectrum of applications in both general and clinical research.

Streamlined Workflows for Sample Preparation

NEB's presentations will delve into streamlined workflows that facilitate the preparation of samples derived from cell-free DNA and RNA. Attendees can look forward to discussions on the Monarch bead-based extraction process and efficient library preparation utilizing the NEBNext Ultra II and UltraExpress DNA and RNA kits. These advanced workflows are designed to save time and resources, ensuring that high-quality data can be obtained even from limited sample inputs.

Epigenetics Exploration with NEBNext Portfolio

Another crucial area of focus will be the NEBNext portfolio's extensions specific to epigenetics research. This includes innovations such as the adapted Enzymatic 5hmC-seq Kit, aimed at locating 5-hydroxymethylcytosine (5hmC), and advanced technologies for enzymatic DNA fragmentation. Moreover, improvements in data analysis techniques will enhance the efficacy of these new technologies, showcasing NEB's dedication to ongoing research and development.

Key Presentations Scheduled

During the conference, various pivotal presentations will unfold at Osprey 5 Suite, featuring distinguished speakers who are making waves in the genomics sphere. Key discussions will encompass:

  • Epigenetic Analysis Then and Now by Ivo Glynne Gut, Ph.D., Director, Centro Nacional de Analisis Genomico.
  • Novel NEBNext Solutions for Epigenetics: EM-seq v2, E5hmC-seq, and UltraShear Fragmentation by Louise Williams, Ph.D., and V.K. Chaithanya Ponnaluri, Ph.D.
  • Streamlined for speed: NEBNext UltraExpress DNA and RNA library prep featuring Dr. Chen Song and Dr. Louise Williams.

These sessions are poised to foster engaging discussions and significant insights into the latest developments in sequencing technology.

Networking Opportunities and Supporting Events

AGBT 2025 is not just about presentations; it’s also an opportunity for networking. Attendees will have numerous chances to interact with NEB's Development Scientists, who will be readily available to discuss the latest advancements and answer questions about innovative technologies.

This year, NEB is proud to be a sponsor of the Women’s Networking event at AGBT, underlining its commitment to fostering diverse and inclusive scientific communities.

About New England Biolabs

For over five decades, New England Biolabs has been a leader in the development and production of innovative products tailored for molecular biology research. The company’s dedication to scientific advancement is reflected in its ever-growing product portfolio and robust support for both academic and commercial research. NEB is firmly rooted in its founding principles, focusing on improving employee well-being, nurturing surrounding communities, and promoting environmental sustainability. With headquarters in Ipswich and a substantial global presence, NEB remains committed to enhancing the future of science and technology.

Frequently Asked Questions

What is New England Biolabs presenting at AGBT 2025?

NEB will showcase innovative technologies for sample preparation aimed at producing high-quality sequencing data.

What are some of the key products being discussed?

Highlights will include the NEBNext Enzymatic Methyl-seq v2 kit and new epigenetics solutions.

Where will the conference be held?

The AGBT 2025 meeting will take place at Marco Island, Florida.

Who are the featured speakers from NEB?

Notable speakers include Dr. Ivo Glynne Gut, Dr. Louise Williams, and Dr. Chen Song.

How does NEB support scientific research?

NEB is dedicated to investing in research and technology that supports both academia and industry in molecular biology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles